Successfully obtained in the EU CE access certification.

Clinical significance：

S100β is a specific marker for brain injury, which is rapidly released into the blood when brain injury occurs, causing an increase in S100β level. Detecting S100β level in the blood can help doctors to detect brain injury at an early stage, assess the degree of injury and judge the prognosis, which is of great significance in improving the prognosis of patients and reducing the economic burden.

Main clinical applications：

1. Early diagnosis, severity and prognosis assessment of brain injury;

2. Early diagnosis of stroke (cerebral infarction and cerebral hemorrhage), assessment of the degree of brain damage and prognosis;

3. Early diagnosis of central nervous system infections (meningitis), disease assessment and treatment monitoring;

4. Early diagnosis and assessment of brain damage caused by various types of neonatal encephalopathies.

Applicable departments: 

Neurology, Neurosurgery, Neonatology, Pediatrics, Geriatrics, Emergency, Cardiology, Surgery,etc